Kailera Therapeutics, Inc. (KLRA)
10.87
-0.46
(-4.06%)
USD |
NASDAQ |
Oct 13, 14:53
Kailera Therapeutics Total Assets (Quarterly) : 1.211B for June 30, 2026
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.211B |
| Date | Value |
|---|---|
| March 31, 2026 | 624.76M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Twist Bioscience Corp. | 672.44M |
| Prime Medicine, Inc. | 249.04M |
| GRAIL, Inc. | 2.844B |
| Arrowhead Pharmaceuticals, Inc. | 2.112B |
| Oncolytics Biotech, Inc. | 7.671M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 92.95M |
| Shareholders Equity (Quarterly) | 1.118B |
| Debt to Equity Ratio | 0.0091 |
| Current Ratio | 11.11 |